Media & Resources

Filter by

Type
- All types
- Fact Sheets & Publications
- Features
- IAVI Report
- In The News
- Podcasts
- Press Releases
- Scientific Publications
- Vaccine Literacy Library
- Videos
Health area
- Clinical trials(2)
- COVID-19(60)
- Ebola Sudan(40)
- EID(2)
- Emerging infectious diseases(2)
- Global access(13)
- HIV(409)
- Lassa fever(42)
- Lassa virus(1)
- Malaria(1)
- Marburg(18)
- Marburg virus(1)
- Neglecte Tropical Diseases (NTDs)(1)
- Other(103)
- Sexually transmitted infections(1)
- Snakebite(7)
- Sudan virus(9)
- TB(1)
- Tuberculosis(83)
- Vaccine research(20)
Location
- Africa(253)
- Europe(34)
- Global(476)
- India(17)
- Japan(1)
- United States(27)
- US(4)
- USA(3)
- Washington(1)
Topic
- Access(19)
- Antibodies(92)
- Capacity strengthening(13)
- Clinical trials(117)
- Community engagement(43)
- Emerging infectious diseases(1)
- Epidemiology(43)
- Funding(46)
- Germline targeting(5)
- Global access(8)
- Key populations(8)
- Pandemic preparedness(31)
- Partnerships(42)
- People(61)
- Policy and advocacy(48)
- Regulatory pathways(6)
- Social-behavioral research(3)
- Vaccine research(257)
Year
Journal
- Acta Crystallogr. D Biol. Crystallogr.(1)
- Addict Behav Rep(1)
- Afr J Lab Med(1)
- AIDS(41)
- AIDS Behav(10)
- AIDS Behav.(1)
- AIDS Care(5)
- AIDS Patient Care STDS(1)
- AIDS Res Hum Retroviruses(25)
- AIDS Res Ther(1)
- Am J Mens Health(1)
- Am J Public Health(1)
- Anal. Biochem.(1)
- Angew. Chem. Int. Ed. Engl.(2)
- Ann. Hum. Genet.(1)
- Ann. Intern. Med.(1)
- Ann. N. Y. Acad. Sci.(1)
- Ann. Oncol.(1)
- Annu. Rev. Immunol.(1)
- Annu. Rev. Med.(1)
- Biochemistry(3)
- Biologicals(3)
- Biomolecules(1)
- Biores Open Access(1)
- bioRxiv(1)
- Biotechnol Bioeng(2)
- Biotechnol J(1)
- Blood(1)
- BMC Biochem.(1)
- BMC Global Public Health(1)
- BMC Health Serv Res(2)
- BMC Immunol.(1)
- BMC Infect Dis(6)
- BMC Infect Dis.(1)
- BMC Med(2)
- BMC Med Educ(1)
- BMC Med Res Methodol(1)
- BMC Public Health(7)
- BMC Res Notes(1)
- BMC Womens Health(2)
- BMJ Glob Health(1)
- BMJ Open(2)
- Br. Med. Bull.(1)
- Bull. World Health Organ.(1)
- Campbell Syst Rev(1)
- Cell(10)
- Cell Chem Biol(1)
- Cell Host Microbe(2)
- Cell Rep(15)
- Chem Asian J(1)
- Chem. Biol.(1)
- Chem. Commun. (Camb.)(1)
- Clin Infect Dis(4)
- Clin. Vaccine Immunol.(3)
- Cogent Med(1)
- Contemp Clin Trials Commun(1)
- Contraception(3)
- Cult Health Sex(1)
- Curr Opin HIV AIDS(5)
- Curr. HIV Res.(1)
- Curr. Opin. Biotechnol.(1)
- Curr. Opin. Immunol.(3)
- Curr. Opin. Mol. Ther.(1)
- Curr. Opin. Struct. Biol.(1)
- Curr. Pharm. Des.(1)
- Curr. Top. Microbiol. Immunol.(1)
- Current Opinion in HIV and AIDS(1)
- East Afr Med J(2)
- eBioMedicine(3)
- Elife(1)
- Epidemiol. Infect.(1)
- Epidemiology(1)
- Eur. J. Immunol.(2)
- Expert Rev Vaccines(7)
- FASEB J.(1)
- Front Cell Infect Microbiol(1)
- Front Immunol(14)
- Front Microbiol(2)
- Front Public Health(1)
- Front Reprod Health(2)
- Gates Open Res(1)
- Gene Ther.(1)
- Genes Immun.(3)
- Global Health(1)
- Glycobiology(3)
- Health Aff (Millwood)(2)
- Health Policy(1)
- Health Promot Int(1)
- Health Res Policy Syst(1)
- HIV Med(1)
- Hum Vaccin(2)
- Hum Vaccin Immunother(2)
- Hum. Genet.(1)
- Human Vaccines & Immunotherapeutics(1)
- IJID Reg(1)
- Immunity(30)
- Immunol. Rev.(4)
- Indian J Pediatr(2)
- Indian J. Med. Res.(4)
- Int Health(3)
- Int J Epidemiol(2)
- Int J Med Inform(2)
- Int J STD AIDS(4)
- J Adv Manuf Process(1)
- J Antimicrob Chemother(1)
- J Comput Chem(1)
- J Exp Med(1)
- J Family Med Prim Care(1)
- J HIV AIDS Surveill Epidemiol(1)
- J Immunol(16)
- J Infect Dis(16)
- J Int AIDS Soc(14)
- J Pharm Sci(2)
- J Womens Health (Larchmt)(1)
- J. Acquir. Immune Defic. Syndr.(16)
- J. Am. Chem. Soc.(3)
- J. Am. Soc. Mass Spectrom.(1)
- J. Biol. Chem.(9)
- J. Clin. Invest.(2)
- J. Clin. Microbiol.(1)
- J. Exp. Med.(11)
- J. Gen. Virol.(11)
- J. Hepatol.(1)
- J. Immunol. Methods(9)
- J. Med. Primatol.(1)
- J. Mol. Biol.(6)
- J. Pept. Sci.(1)
- J. Virol.(115)
- J. Virol. Methods(2)
- JCI Insight(1)
- JMIR Res Protoc(1)
- Lancet(12)
- Lancet Glob Health(1)
- Lancet HIV(3)
- Lancet Infect Dis(3)
- lancet microbe(2)
- Lancet Respir Med(1)
- mBio(4)
- medRxiv(1)
- Methods Mol. Med.(1)
- Microbiol Spectr(2)
- Microorganisms(1)
- Mol Ther Methods Clin Dev(1)
- Mol. Ther.(3)
- Mucosal Immunol(1)
- N. Engl. J. Med.(7)
- Nat Commun(18)
- Nat Immunol(2)
- Nat Med(15)
- Nat Microbiol(2)
- Nat. Biotechnol.(1)
- Nat. Chem. Biol.(1)
- Nat. Immunol.(5)
- Nat. Rev. Immunol.(1)
- Nat. Rev. Microbiol.(1)
- Nat. Struct. Mol. Biol.(4)
- Nature(20)
- NEJM(1)
- npj Vaccines(3)
- Nucleic Acids Res.(1)
- Open Forum Infect Dis(2)
- Org. Biomol. Chem.(1)
- Orphanet J Rare Dis.(1)
- Pan Afr Med J(3)
- PDA J Pharm Sci Technol(1)
- Pharmaceut Med(1)
- Pharmacoeconomics(2)
- PLoS Glob Public Health(7)
- PLoS Med.(5)
- PLoS Negl Trop Dis(1)
- PLoS One(86)
- PLoS Pathog(36)
- Proc Natl Acad Sci U S A(32)
- Proteins(1)
- Proteomics(2)
- Rapid Commun. Mass Spectrom.(1)
- Res Involv Engagem(1)
- Retrovirology(13)
- Rev. Med. Virol.(1)
- S. Afr. Med. J.(1)
- Sci Adv(2)
- Sci Immunol(5)
- Sci Rep(8)
- Sci Transl Med(11)
- Science(38)
- Sex Health(1)
- Sex Transm Dis(4)
- Sex Transm Infect(12)
- Southeast Asian J. Trop. Med. Public Health(1)
- Springerplus(1)
- Structure(4)
- Stud Fam Plann(1)
- Syst Rev(1)
- Ther Adv Vaccines(1)
- Top HIV Med(1)
- Toxins(1)
- Trends Microbiol.(1)
- Trends Parasitol(1)
- Trop Dis Travel Med Vaccines(1)
- Trop. Med. Int. Health(7)
- Vaccine(33)
- Vaccines (Basel)(3)
- Virology(36)
- Viruses(1)
- Wellcome Open Res(1)
- Women's Health (Lond)(1)
Publication
- AARP(1)
- ABC 10 News in San Diego,(1)
- ABC News(1)
- ABCNEWS(1)
- AFP News(1)
- AIDSmap(1)
- ANI(1)
- Apna Radio 96.9 fm(1)
- AVAC(1)
- BBC(1)
- BioSpace,(1)
- BioWorld,(1)
- Bloomberg(4)
- Bloomberg Businessweek(1)
- BNN Bloomberg(1)
- Business Daily(1)
- Business Insider(2)
- Center for Global Development(1)
- CEPI(2)
- CGTN(1)
- Chemical & Engineering News(1)
- CIDRAP(4)
- Clinical Trials Arena(2)
- CNBC(1)
- CNN(4)
- CNN International(1)
- Contagion Live(1)
- Cope,(1)
- CSIS(1)
- CSIS Global Health Policy Center(1)
- Daily Mail(1)
- Daily Maverick(1)
- Daily Nation(2)
- Devex(7)
- Drug Discovery & Development,(1)
- Ebru TV (video)(1)
- Economic Times(1)
- El Confidencial(1)
- El Español,(1)
- El Global,(1)
- El País(2)
- EndPoints News(1)
- Es Radio Albacete,(1)
- ETHealthWorld (video)(1)
- EU Observer(1)
- European Commission(1)
- Fierce Pharma,(1)
- Financial Times(1)
- Fox News,(1)
- Gates Foundation(1)
- Gavi(7)
- GEN,(1)
- GeneOnline(1)
- Genetic Engineering & Biotechnology News(1)
- Global Health NOW(1)
- Global Health Technologies Coalition(1)
- HCP Live,(1)
- Health Affairs,(1)
- Health Analytics Asia(1)
- Health Policy Watch(2)
- Hutch News Service(1)
- Indian Express(2)
- Inside Precision Medicine(1)
- International Business Times,(1)
- International Development Research Centre(1)
- La Razón(1)
- La Razón,(1)
- La Tribuna de Albacete(1)
- La Voz de Galicia(1)
- Le Monde(1)
- Los Angeles Times(2)
- Managed Healthcare Executive(2)
- Medical New Today(1)
- MedPage Today(1)
- Memorias(1)
- mosaic(1)
- Nasdaq,(1)
- National Geographic(1)
- National Review(1)
- Nature(6)
- Nature Biotechnology(1)
- Nature India(1)
- NBC News(1)
- New Scientist(1)
- News 18 India(1)
- Newsweek(1)
- NIAID(1)
- Nigeria Health Watch(3)
- Nigerian Television Authority(1)
- NPR(1)
- NPR Goats & Soda(1)
- NPR Goats and Soda(1)
- Person Place Thing (podcast)(1)
- PharmaVoice(1)
- Pindula(1)
- Politico(1)
- Popular Science(1)
- Positively Aware(1)
- Posterity Media(1)
- POZ(2)
- Precision Vaccinations,(1)
- ProPatiens(1)
- ProPatients(2)
- Pulse Nigeria(1)
- Refinery 29(1)
- Results UK(1)
- Reuters(2)
- Reuters,(1)
- Rolling Stone(1)
- Salon(2)
- Sayansi Magazine(1)
- SciDevNet,(2)
- Science(9)
- ScienceNews(1)
- Scroll.in(1)
- Spotlight(1)
- Standard(1)
- STAT(7)
- STAT News(13)
- STAT Plus (Subscription Required)(2)
- TechCrunch,(1)
- Telecinco,(2)
- The Advocate(1)
- The Associated Press(1)
- The BMJ(1)
- The Conversation(1)
- The Daily Nation(2)
- The Guardian(2)
- The Guardian Nigeria(2)
- The HILL(3)
- The Indian Express(1)
- THE LANCET(4)
- The New Times(1)
- The New York Times(3)
- The Observer(1)
- The Philadelphia Inquirer(1)
- The Standard(1)
- The Star(1)
- The Telegraph(4)
- The Voice of America(1)
- The Wall Street Journal(1)
- The Washington Post(2)
- The Wire(2)
- them.(1)
- TIDES Global(1)
- Times of India(2)
- USAID Blog(1)
- Vaccine Insights(1)
- VaccinesToday(1)
- VICE(1)
- Wall Street Journal,(1)
- WebMD(1)
- Weill Cornell(1)
- WIRED(1)
- World Health Organization(2)
- World Pharmaceutical Frontiers(1)
- Yale School of Medicine(1)
- Zendal(1)
Fact sheet & publication type
- Annual Reports(7)
- Community Engagement Resources(15)
- Fact Sheets(12)
- Policy and Advocacy Publications(23)
Keyword search
Clear all

Features

IAVI announces enrollment of cohort of people without tuberculosis (TB) infection in Phase 2b trial of TB vaccine candidate MTBVAC

February 23, 2026

Additional enrollment of 1,200 participants could ultimately enable a fast track to licensure

In The News

New vaccine platform promotes rare protective B cells

MIT News

February 5, 2026

Features

Ending neglected diseases requires partners willing to go where markets won’t

January 29, 2026

~ An IAVI Statement on World Neglected Tropical Diseases (NTDs) Day 2026 ~

Features

IAVI and Partners Announce the 8th Global Forum on TB Vaccines in April 2027 in Zaragoza, Spain

January 23, 2026

The 8th Global Forum will take place from April 12-14, 2027—marking a return to the European region and the first time in a Spanish-speaking country

Features

Epidemiology studies strengthening data management capacity for future Lassa fever vaccine trials in Sierra Leone: a conversation with Foday Alhasan

January 14, 2026

Strengthening data management capacities is helping ensure institutional readiness for future Lassa fever vaccine trials in Sierra Leone

In The News

IAVI builds on clinical success with three-pronged mRNA vaccine against HIV

BioXconomy

January 13, 2026

In The News

IAVI Announces First Vaccinations in a Phase I Trial of a Promising HIV Vaccine Approach

Poz

January 7, 2026

Press Releases

IAVI announces first vaccinations in IAVI G004, a Phase 1 clinical trial of a promising HIV vaccine approach

January 6, 2026

Study will examine safety, immune response, and dose of three promising immunogens

12 3…247 of 247

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

IAVI announces enrollment of cohort of people without tuberculosis (TB) infection in Phase 2b trial of TB vaccine candidate MTBVAC

New vaccine platform promotes rare protective B cells

Ending neglected diseases requires partners willing to go where markets won’t

IAVI and Partners Announce the 8th Global Forum on TB Vaccines in April 2027 in Zaragoza, Spain

Epidemiology studies strengthening data management capacity for future Lassa fever vaccine trials in Sierra Leone: a conversation with Foday Alhasan

IAVI builds on clinical success with three-pronged mRNA vaccine against HIV

IAVI Announces First Vaccinations in a Phase I Trial of a Promising HIV Vaccine Approach

IAVI announces first vaccinations in IAVI G004, a Phase 1 clinical trial of a promising HIV vaccine approach

Subscription Type